Citadel Advisors
TIL icon

Citadel Advisors’s Instil Bio TIL Stock Holding History

Citadel Advisors’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-465
Closed -$3.98K – 15258
2023
Q3 		$3.98K Sell
465
-110
-19% -$1.11K ﹤0.01% 13527
2023
Q2 		$6.34K Sell
575
-295
-34% -$3.61K ﹤0.01% 13431
2023
Q1 		$11.5K Buy
870
+660
+314% +$9.75K ﹤0.01% 13474
2022
Q4 		$2.65K Buy
+210
New +$10.4K ﹤0.01% 14304

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Citadel Advisors's TIL Position: Q1 2026 in Review

Citadel Advisors reduced its Instil Bio (TIL) stake by 19% in Q1 2026, selling an estimated $71.2K and leaving 38,562 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #10347.

Citadel Advisors first reported a position in TIL in Q1 2021 and has held it in 13 quarters since. The position peaked at $2.38M in Q1 2022. 32 funds tracked by Wall St. Rank hold TIL as of Q1 2026.

  • Citadel Advisors held 38,562 shares of Instil Bio worth $318K as of Q1 2026.
  • Citadel Advisors sold 8,773 Instil Bio shares in Q1 2026, an estimated $71.2K.
  • Instil Bio made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #10347 holding.
  • Citadel Advisors first reported a position in Instil Bio in Q1 2021 and has held it in 13 quarters since.
  • Citadel Advisors's Instil Bio position peaked at $2.38M in Q1 2022.
  • 32 funds tracked by Wall St. Rank held Instil Bio as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.